RAPT Therapeutics to Participate in Upcoming Investor Conferences
November 08 2021 - 8:00AM
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage,
immunology-based biopharmaceutical company focused on
discovering, developing and commercializing oral small molecule
therapies for patients with significant unmet needs in inflammatory
diseases and oncology, today announced that Brian Wong, M.D.,
Ph.D., President and CEO, will present at the following investor
conferences in November:
- Stifel 2021 Virtual
Healthcare Conference – Company presentation on Monday,
November 15, 2021, at 2:00 p.m. ET
- Piper Sandler 33rd Annual
Virtual Healthcare Conference – Pre-recorded fireside chat
available on-demand Monday, November 22, 2021, at 10:00 a.m.
ET
To access the live webcast or subsequent archived recordings of
the company presentations, please visit the RAPT Therapeutics
website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.RAPT
Therapeutics is a clinical stage immunology-based biopharmaceutical
company focused on discovering, developing and commercializing oral
small molecule therapies for patients with significant unmet needs
in oncology and inflammatory diseases. Utilizing its proprietary
discovery and development engine, the Company is developing highly
selective small molecules designed to modulate the critical immune
drivers underlying these diseases. RAPT has discovered and advanced
two unique drug candidates, RPT193 and FLX475, each targeting C-C
motif chemokine receptor 4 (CCR4), for the treatment of
inflammatory diseases and cancer, respectively. The Company is also
pursuing a range of targets that are in the discovery stage of
development.
RAPT Media Contact:Aljanae
Reynoldsareynolds@wheelhouselsa.com
RAPT Investor Contact:Sylvia
Wheelerswheeler@wheelhouselsa.com
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Sep 2023 to Sep 2024